Researchers identify a new HIV reservoir

April 17, 2017
HIV infecting a human cell. Credit: NIH

HIV cure research to date has focused on clearing the virus from T cells, a type of white blood cell that is an essential part of the immune system. Yet investigators in the Division of Infectious Diseases at the University of North Carolina School of Medicine have found the virus persists in HIV-infected macrophages. Macrophages are large white blood cells found in tissues throughout the body including the liver, lung, bone marrow and brain. The discovery of this additional viral reservoir has significant implications for HIV cure research. These findings were published in Nature Medicine on Monday, April 17.

"These results are paradigm changing because they demonstrate that cells other than T cells can serve as a reservoir for HIV," said Jenna Honeycutt, Ph.D., lead-author and postdoctoral research associate in the UNC Division of Infectious Diseases. "The fact that HIV-infected macrophages can persist means that any possible therapeutic intervention to eradicate HIV might have to target two very different types of cells."

Last spring, this laboratory lead by J. Victor Garcia, Ph. D., professor of medicine, microbiology and immunology at UNC School of Medicine, demonstrated the ability of to support HIV replication in vivo in the total absence of human T cells. But how macrophages would respond to antiretroviral therapy (ART) and whether macrophages represented a reservoir for HIV after treatment were unknown.

Macrophages are myeloid lineage cells that have been implicated in HIV pathogenesis and in the trafficking of virus into the brain. Using a humanized myeloid-only mouse (MoM) model devoid of T cells, Garcia and his team showed that ART strongly suppresses HIV replication in tissue macrophages. Yet when HIV treatment was interrupted, viral rebound was observed in one third of the animals. This is consistent with the establishment of persistent infection in tissue macrophages.

"This is the first report demonstrating that tissue macrophages can be infected and that they respond to antiretroviral therapy," Honeycutt said. "In addition, we show that productively infected macrophages can persist despite ART; and most importantly, that they can reinitiate and sustain infection upon therapy interruption even in the absence of T cells—the major target of HIV infection."

Now that Garcia and his team know HIV persists in macrophages, the next step will be to determine what regulates HIV persistence in tissue macrophages, where in the body persistently infected macrophages reside during HIV treatment and how macrophages respond to possible therapeutic interventions aimed at eradicating HIV from the body.

Explore further: Researchers prove HIV targets tissue macrophages

More information: HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy, Nature Medicine (2017). nature.com/articles/doi:10.1038/nm.4319

Related Stories

Researchers prove HIV targets tissue macrophages

March 8, 2016
Investigators in the Division of Infectious Diseases at the University of North Carolina School of Medicine have clearly demonstrated that HIV infects and reproduces in macrophages, large white blood cells found in the liver, ...

Silence is golden—Suppressing host response to Ebola virus may help to control infection

March 22, 2017
The Ebola virus causes a severe, often fatal illness when it infects the human body. Initially targeting cells of the immune system called macrophages, white blood cells that absorb and clear away pathogens, a new study has ...

Study shows how HIV breaches macrophage defenses, could be step towards cure

January 25, 2017
A team led by UCL researchers has identified how HIV is able to infect macrophages, a type of white blood cell integral to the immune system, despite the presence of a protective protein. They discovered a treatment that ...

Immune cells proposed as HIV hideout don't last in primate model

October 31, 2014
Where does HIV hide? Antiretroviral drugs can usually control the virus, but can't completely eliminate it. So any strategy to eradicate HIV from the body has to take into account not only the main group of immune cells the ...

Insulin resistance reversed by removal of protein

November 3, 2016
By removing the protein galectin-3 (Gal3), a team of investigators led by University of California School of Medicine researchers were able to reverse diabetic insulin resistance and glucose intolerance in mouse models of ...

The immune system-body weight connection

August 24, 2016
A primary role of the immune system is fighting off harmful bacteria and viruses. However, recent studies have revealed additional roles of immune cells in other important host functions, such as controlling body weight.

Recommended for you

Candidate AIDS vaccine passes early test

July 24, 2017
The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.

Girl's HIV infection seems under control without AIDS drugs

July 24, 2017
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines—more evidence that early treatment can occasionally cause a long remission that, ...

Meds by monthly injection might revolutionize HIV care (Update)

July 24, 2017
Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay.

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

deloachjuan
not rated yet Jun 14, 2017
Why are you still in pain why are you suffering when Dr Olori has the solution to your problems. Hello viewers i am Juan by name i want to use this medium to tell you that Dr Olori have herbs for all kinds of diseases such as, HIV, Herpes, Diabetes and lots more am so happy sharing this testimony cause Dr Olori indeed helped me when i was kind of weigh down when i was fighting this HIV virus but thank God that am now whole again with the help of DR Olori kindly give a try to his herbal medicine so you could testify just like me. Here is hes information on how you can get in touch with him at
(droloriherbalcenter@gmail.com) or ring his mobile (+2349053311935). Do not hesitate to contact him of any problem now i believe the saying that says seeing is believing, Thanks and God bless.
angelaslaughter
not rated yet Jun 15, 2017
Please Read.

* GONORRHEA,
* ZIKA VIRUS
* TYPHOID,
* HEPATITIS,
* DIABETES,
* HERPES VIRUS,
* LASSA FEVER,
* MENINGITIS,
* RABIES,
* SYPHILIS,
* HIV,
* CANCER,
* ALS,
* SHINGLES,
* JAUNDICE,
* PARKINSON and so on.

To get herbal cure for the above diseases, contact Dr Solutionwhats app him on his mobile number: +2348077683109.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.